PH27000A - Heteroaryl derivatives and pharmaceutical compositions containing them - Google Patents
Heteroaryl derivatives and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- PH27000A PH27000A PH36319A PH36319A PH27000A PH 27000 A PH27000 A PH 27000A PH 36319 A PH36319 A PH 36319A PH 36319 A PH36319 A PH 36319A PH 27000 A PH27000 A PH 27000A
- Authority
- PH
- Philippines
- Prior art keywords
- phenyl
- dihydro
- oxo
- propanamide
- pyrazol
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 6
- 125000001072 heteroaryl group Chemical group 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 125
- 125000000217 alkyl group Chemical group 0.000 claims description 55
- -1 nitro, amino Chemical group 0.000 claims description 23
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 22
- 125000003545 alkoxy group Chemical group 0.000 claims description 21
- 229910052739 hydrogen Inorganic materials 0.000 claims description 21
- 239000001257 hydrogen Substances 0.000 claims description 21
- 229910052736 halogen Inorganic materials 0.000 claims description 19
- 150000002367 halogens Chemical group 0.000 claims description 19
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 14
- 125000001424 substituent group Chemical group 0.000 claims description 11
- 125000005236 alkanoylamino group Chemical group 0.000 claims description 9
- 150000002431 hydrogen Chemical class 0.000 claims description 9
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 7
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 7
- 125000004076 pyridyl group Chemical group 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 5
- 239000003085 diluting agent Substances 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- 239000005864 Sulphur Chemical group 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- VXLCNTLWWUDBSO-UHFFFAOYSA-N Ethiazide Chemical compound ClC1=C(S(N)(=O)=O)C=C2S(=O)(=O)NC(CC)NC2=C1 VXLCNTLWWUDBSO-UHFFFAOYSA-N 0.000 claims 1
- 241001275899 Salta Species 0.000 claims 1
- 235000013350 formula milk Nutrition 0.000 description 82
- 125000004289 pyrazol-3-yl group Chemical group [H]N1N=C(*)C([H])=C1[H] 0.000 description 75
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 26
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 21
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- 239000002244 precipitate Substances 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- 238000003756 stirring Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000011541 reaction mixture Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 14
- 239000005457 ice water Substances 0.000 description 14
- 238000011282 treatment Methods 0.000 description 13
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 208000015181 infectious disease Diseases 0.000 description 11
- 229910000104 sodium hydride Inorganic materials 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 239000012312 sodium hydride Substances 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 238000001816 cooling Methods 0.000 description 8
- 238000002425 crystallisation Methods 0.000 description 8
- 230000008025 crystallization Effects 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 125000004997 halocarbonyl group Chemical group 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000003826 tablet Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000012442 inert solvent Substances 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Substances [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 5
- ACHCVNZWYGDXIZ-UHFFFAOYSA-N n-benzyl-2-cyano-3-oxo-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound N=1N(C=2C=CC=CC=2)C(C2=CC=CC=C2SC2)=C2C=1C(=O)C(C#N)C(=O)NCC1=CC=CC=C1 ACHCVNZWYGDXIZ-UHFFFAOYSA-N 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 239000008096 xylene Substances 0.000 description 5
- BGOWFIJRIJEOHH-UHFFFAOYSA-N 2-cyano-3-oxo-n-phenyl-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound N=1N(C=2C=CC=CC=2)C(C2=CC=CC=C2SC2)=C2C=1C(=O)C(C#N)C(=O)NC1=CC=CC=C1 BGOWFIJRIJEOHH-UHFFFAOYSA-N 0.000 description 4
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 230000002519 immonomodulatory effect Effects 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 125000004423 acyloxy group Chemical group 0.000 description 3
- 125000005233 alkylalcohol group Chemical group 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 229940057948 magnesium stearate Drugs 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- RLNPJOTVKKWVKP-UHFFFAOYSA-N n-benzyl-2-cyano-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound N=1N(C=2C=CC=CC=2)C(C2=CC=CC=C2OC2)=C2C=1C(=O)C(C#N)C(=O)NCC1=CC=CC=C1 RLNPJOTVKKWVKP-UHFFFAOYSA-N 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- VCXQYCYMMROSGW-UHFFFAOYSA-N 1-phenyl-4h-thiochromeno[4,3-c]pyrazole-3-carbonyl chloride Chemical compound C1SC2=CC=CC=C2C2=C1C(C(=O)Cl)=NN2C1=CC=CC=C1 VCXQYCYMMROSGW-UHFFFAOYSA-N 0.000 description 2
- KOPFEFZSAMLEHK-UHFFFAOYSA-N 1h-pyrazole-5-carboxylic acid Chemical compound OC(=O)C=1C=CNN=1 KOPFEFZSAMLEHK-UHFFFAOYSA-N 0.000 description 2
- STOQDQKQPUUXKF-UHFFFAOYSA-N 2-cyano-3-oxo-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)-n-[3-(trifluoromethyl)phenyl]propanamide Chemical compound FC(F)(F)C1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4SC3)N(N=2)C=2C=CC=CC=2)=C1 STOQDQKQPUUXKF-UHFFFAOYSA-N 0.000 description 2
- PLAWGBUYOMFEGY-UHFFFAOYSA-N 2-cyano-3-oxo-n-phenyl-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound N=1N(C=2C=CC=CC=2)C(C2=CC=CC=C2OC2)=C2C=1C(=O)C(C#N)C(=O)NC1=CC=CC=C1 PLAWGBUYOMFEGY-UHFFFAOYSA-N 0.000 description 2
- RLKIZXFGDAHRML-UHFFFAOYSA-N 2-cyano-n-(4-fluorophenyl)-3-[1-(4-fluorophenyl)-4h-thiochromeno[4,3-c]pyrazol-3-yl]-3-oxopropanamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C#N)C(=O)C1=NN(C=2C=CC(F)=CC=2)C2=C1CSC1=CC=CC=C21 RLKIZXFGDAHRML-UHFFFAOYSA-N 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000186779 Listeria monocytogenes Species 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 125000003302 alkenyloxy group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- MLIREBYILWEBDM-UHFFFAOYSA-N cyanoacetic acid Chemical compound OC(=O)CC#N MLIREBYILWEBDM-UHFFFAOYSA-N 0.000 description 2
- 229960004397 cyclophosphamide Drugs 0.000 description 2
- 235000013681 dietary sucrose Nutrition 0.000 description 2
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ZIUSEGSNTOUIPT-UHFFFAOYSA-N ethyl 2-cyanoacetate Chemical compound CCOC(=O)CC#N ZIUSEGSNTOUIPT-UHFFFAOYSA-N 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 229960002900 methylcellulose Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 2
- QKFJKGMPGYROCL-UHFFFAOYSA-N phenyl isothiocyanate Chemical compound S=C=NC1=CC=CC=C1 QKFJKGMPGYROCL-UHFFFAOYSA-N 0.000 description 2
- HKOOXMFOFWEVGF-UHFFFAOYSA-N phenylhydrazine Chemical compound NNC1=CC=CC=C1 HKOOXMFOFWEVGF-UHFFFAOYSA-N 0.000 description 2
- 229940067157 phenylhydrazine Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 159000000001 potassium salts Chemical class 0.000 description 2
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 229940033134 talc Drugs 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- YWWKXKQNHSMQCR-UHFFFAOYSA-N 1-oxo-2,3-dihydrothiochromen-4-one Chemical class C1=CC=C2C(=O)CCS(=O)C2=C1 YWWKXKQNHSMQCR-UHFFFAOYSA-N 0.000 description 1
- VGCQENNQMPLURG-UHFFFAOYSA-N 1-phenyl-4h-chromeno[4,3-c]pyrazole-3-carbonyl chloride Chemical compound C1OC2=CC=CC=C2C2=C1C(C(=O)Cl)=NN2C1=CC=CC=C1 VGCQENNQMPLURG-UHFFFAOYSA-N 0.000 description 1
- KGCPHZNGYDYXTL-UHFFFAOYSA-N 1-phenyl-4h-thiochromeno[4,3-c]pyrazole-3-carboxylic acid Chemical compound C1SC2=CC=CC=C2C2=C1C(C(=O)O)=NN2C1=CC=CC=C1 KGCPHZNGYDYXTL-UHFFFAOYSA-N 0.000 description 1
- CVQSWZMJOGOPAV-UHFFFAOYSA-N 2,3-dihydrothiochromen-4-one Chemical class C1=CC=C2C(=O)CCSC2=C1 CVQSWZMJOGOPAV-UHFFFAOYSA-N 0.000 description 1
- KLYRLYNXBRHFBU-UHFFFAOYSA-N 2-cyano-3-(4-methyl-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-3-oxo-n-phenylpropanamide Chemical compound CC1OC2=CC=CC=C2C2=C1C(C(=O)C(C#N)C(=O)NC=1C=CC=CC=1)=NN2C1=CC=CC=C1 KLYRLYNXBRHFBU-UHFFFAOYSA-N 0.000 description 1
- SHJJYJJGAAEISB-UHFFFAOYSA-N 2-cyano-3-[1-(3,5-dichlorophenyl)-4h-thiochromeno[4,3-c]pyrazol-3-yl]-3-oxo-n-phenylpropanamide Chemical compound ClC1=CC(Cl)=CC(N2C=3C4=CC=CC=C4SCC=3C(C(=O)C(C#N)C(=O)NC=3C=CC=CC=3)=N2)=C1 SHJJYJJGAAEISB-UHFFFAOYSA-N 0.000 description 1
- JXPXGSMZQIHLSP-UHFFFAOYSA-N 2-cyano-3-[1-(3,5-dichlorophenyl)-4h-thiochromeno[4,3-c]pyrazol-3-yl]-n-(4-fluorophenyl)-3-oxopropanamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C#N)C(=O)C1=NN(C=2C=C(Cl)C=C(Cl)C=2)C2=C1CSC1=CC=CC=C21 JXPXGSMZQIHLSP-UHFFFAOYSA-N 0.000 description 1
- XWTYZNWYISQBPG-UHFFFAOYSA-N 2-cyano-3-[1-(3-methylphenyl)-4h-chromeno[4,3-c]pyrazol-3-yl]-3-oxo-n-phenylpropanamide Chemical compound CC1=CC=CC(N2C=3C4=CC=CC=C4OCC=3C(C(=O)C(C#N)C(=O)NC=3C=CC=CC=3)=N2)=C1 XWTYZNWYISQBPG-UHFFFAOYSA-N 0.000 description 1
- QXKYEOVRJOUJGE-UHFFFAOYSA-N 2-cyano-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-n-[3-(trifluoromethyl)phenyl]propanamide Chemical compound FC(F)(F)C1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4OC3)N(N=2)C=2C=CC=CC=2)=C1 QXKYEOVRJOUJGE-UHFFFAOYSA-N 0.000 description 1
- BXNIILSZVDLNSO-UHFFFAOYSA-N 2-cyano-3-oxo-n-phenyl-3-(1-pyridin-3-yl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound N=1N(C=2C=NC=CC=2)C(C2=CC=CC=C2SC2)=C2C=1C(=O)C(C#N)C(=O)NC1=CC=CC=C1 BXNIILSZVDLNSO-UHFFFAOYSA-N 0.000 description 1
- WNJWIDMSMIVTKL-UHFFFAOYSA-N 2-cyano-3-oxo-n-phenyl-3-[1-[3-(trifluoromethyl)phenyl]-4h-thiochromeno[4,3-c]pyrazol-3-yl]propanamide Chemical compound FC(F)(F)C1=CC=CC(N2C=3C4=CC=CC=C4SCC=3C(C(=O)C(C#N)C(=O)NC=3C=CC=CC=3)=N2)=C1 WNJWIDMSMIVTKL-UHFFFAOYSA-N 0.000 description 1
- KSTLFUQLCKTJQD-UHFFFAOYSA-N 2-cyano-n-(3-hydroxyphenyl)-3-oxo-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound OC1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4SC3)N(N=2)C=2C=CC=CC=2)=C1 KSTLFUQLCKTJQD-UHFFFAOYSA-N 0.000 description 1
- NRBBPWBWIORDCT-UHFFFAOYSA-N 2-cyano-n-(3-methoxyphenyl)-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound COC1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4OC3)N(N=2)C=2C=CC=CC=2)=C1 NRBBPWBWIORDCT-UHFFFAOYSA-N 0.000 description 1
- PFBXWUWFNRMLDF-UHFFFAOYSA-N 2-cyano-n-(3-methylphenyl)-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound CC1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4OC3)N(N=2)C=2C=CC=CC=2)=C1 PFBXWUWFNRMLDF-UHFFFAOYSA-N 0.000 description 1
- YDOYHGBBIIFRJR-UHFFFAOYSA-N 2-cyano-n-(4-fluorophenyl)-3-oxo-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C#N)C(=O)C1=NN(C=2C=CC=CC=2)C2=C1CSC1=CC=CC=C21 YDOYHGBBIIFRJR-UHFFFAOYSA-N 0.000 description 1
- AOHORXITNQMPQT-UHFFFAOYSA-N 2-cyano-n-methyl-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-n-pyridin-2-ylpropanamide Chemical compound C=1C=CC=NC=1N(C)C(=O)C(C#N)C(=O)C(C1=C2C3=CC=CC=C3OC1)=NN2C1=CC=CC=C1 AOHORXITNQMPQT-UHFFFAOYSA-N 0.000 description 1
- QOGGSCIAUTZPDG-UHFFFAOYSA-N 2-cyano-n-methyl-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound C1OC2=CC=CC=C2C2=C1C(C(=O)C(C#N)C(=O)NC)=NN2C1=CC=CC=C1 QOGGSCIAUTZPDG-UHFFFAOYSA-N 0.000 description 1
- XVPPLOYHGYJALT-UHFFFAOYSA-N 2-cyano-n-methyl-3-oxo-n-phenyl-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound C=1C=CC=CC=1N(C)C(=O)C(C#N)C(=O)C(C1=C2C3=CC=CC=C3OC1)=NN2C1=CC=CC=C1 XVPPLOYHGYJALT-UHFFFAOYSA-N 0.000 description 1
- PMEKHNOMXFPLAK-UHFFFAOYSA-N 2-cyano-n-pyridin-2-ylacetamide Chemical compound N#CCC(=O)NC1=CC=CC=N1 PMEKHNOMXFPLAK-UHFFFAOYSA-N 0.000 description 1
- GBXQXWZDYNJVRB-UHFFFAOYSA-N 3-(4-methyl-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-3-oxopropanenitrile Chemical compound CC1OC2=CC=CC=C2C2=C1C(C(=O)CC#N)=NN2C1=CC=CC=C1 GBXQXWZDYNJVRB-UHFFFAOYSA-N 0.000 description 1
- RRIQUPLITGNMHN-UHFFFAOYSA-N 3-(8-acetamido-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-2-cyano-3-oxo-n-phenylpropanamide Chemical compound C1=2C3=CC(NC(=O)C)=CC=C3OCC=2C(C(=O)C(C#N)C(=O)NC=2C=CC=CC=2)=NN1C1=CC=CC=C1 RRIQUPLITGNMHN-UHFFFAOYSA-N 0.000 description 1
- VDYNPNAPWQIFTQ-UHFFFAOYSA-N 3-(8-chloro-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-2-cyano-3-oxo-n-phenylpropanamide Chemical compound C1=2C3=CC(Cl)=CC=C3OCC=2C(C(=O)C(C#N)C(=O)NC=2C=CC=CC=2)=NN1C1=CC=CC=C1 VDYNPNAPWQIFTQ-UHFFFAOYSA-N 0.000 description 1
- KKHMURVHEFLABH-UHFFFAOYSA-N 3-(8-chloro-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-2-cyano-n-(3-fluorophenyl)-3-oxopropanamide Chemical compound FC1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC(Cl)=CC=C4OC3)N(N=2)C=2C=CC=CC=2)=C1 KKHMURVHEFLABH-UHFFFAOYSA-N 0.000 description 1
- JTMBOTUURXATFK-UHFFFAOYSA-N 3-(8-chloro-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-2-cyano-n-(4-fluorophenyl)-3-oxopropanamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C#N)C(=O)C1=NN(C=2C=CC=CC=2)C2=C1COC1=CC=C(Cl)C=C21 JTMBOTUURXATFK-UHFFFAOYSA-N 0.000 description 1
- IIOVLVCDTTVYNA-UHFFFAOYSA-N 3-(8-chloro-1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)-2-cyano-3-oxo-n-phenylpropanamide Chemical compound C1=2C3=CC(Cl)=CC=C3SCC=2C(C(=O)C(C#N)C(=O)NC=2C=CC=CC=2)=NN1C1=CC=CC=C1 IIOVLVCDTTVYNA-UHFFFAOYSA-N 0.000 description 1
- LOYKAQUQXXZDBA-UHFFFAOYSA-N 3-(8-chloro-1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)-2-cyano-n-(4-fluorophenyl)-3-oxopropanamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C#N)C(=O)C1=NN(C=2C=CC=CC=2)C2=C1CSC1=CC=C(Cl)C=C21 LOYKAQUQXXZDBA-UHFFFAOYSA-N 0.000 description 1
- VGSVZQMKHCUQRS-UHFFFAOYSA-N 3-(8-methoxy-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-3-oxopropanenitrile Chemical compound C1=2C3=CC(OC)=CC=C3OCC=2C(C(=O)CC#N)=NN1C1=CC=CC=C1 VGSVZQMKHCUQRS-UHFFFAOYSA-N 0.000 description 1
- OAKURXIZZOAYBC-UHFFFAOYSA-N 3-Oxopropanoic acid Natural products OC(=O)CC=O OAKURXIZZOAYBC-UHFFFAOYSA-N 0.000 description 1
- VMPJTAYGKYHPDW-UHFFFAOYSA-N 3-[1-(3-bromophenyl)-4h-thiochromeno[4,3-c]pyrazol-3-yl]-2-cyano-3-oxo-n-phenylpropanamide Chemical compound BrC1=CC=CC(N2C=3C4=CC=CC=C4SCC=3C(C(=O)C(C#N)C(=O)NC=3C=CC=CC=3)=N2)=C1 VMPJTAYGKYHPDW-UHFFFAOYSA-N 0.000 description 1
- MEGPSCMUIFTMSQ-UHFFFAOYSA-N 3-[1-(3-chlorophenyl)-4h-thiochromeno[4,3-c]pyrazol-3-yl]-2-cyano-n-(4-fluorophenyl)-3-oxopropanamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C#N)C(=O)C1=NN(C=2C=C(Cl)C=CC=2)C2=C1CSC1=CC=CC=C21 MEGPSCMUIFTMSQ-UHFFFAOYSA-N 0.000 description 1
- FAXDLNNAFZKVSK-UHFFFAOYSA-N 3-[1-(4-chlorophenyl)-4h-chromeno[4,3-c]pyrazol-3-yl]-3-oxopropanenitrile Chemical compound C1=CC(Cl)=CC=C1N1C(C2=CC=CC=C2OC2)=C2C(C(=O)CC#N)=N1 FAXDLNNAFZKVSK-UHFFFAOYSA-N 0.000 description 1
- KUKFFVKSYVGFKB-UHFFFAOYSA-N 3-[1-(4-fluorophenyl)-4h-chromeno[4,3-c]pyrazol-3-yl]-3-oxopropanenitrile Chemical compound C1=CC(F)=CC=C1N1C(C2=CC=CC=C2OC2)=C2C(C(=O)CC#N)=N1 KUKFFVKSYVGFKB-UHFFFAOYSA-N 0.000 description 1
- ZZVWZTRCAOCHSV-UHFFFAOYSA-N 3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanenitrile Chemical compound C1OC2=CC=CC=C2C2=C1C(C(CC#N)=O)=NN2C1=CC=CC=C1 ZZVWZTRCAOCHSV-UHFFFAOYSA-N 0.000 description 1
- OFZFFIDUIUEPIB-UHFFFAOYSA-N 3-oxopropanamide Chemical compound NC(=O)CC=O OFZFFIDUIUEPIB-UHFFFAOYSA-N 0.000 description 1
- VYIBCOSBNVFEIW-UHFFFAOYSA-N 3-phenylpropanamide Chemical compound NC(=O)CCC1=CC=CC=C1 VYIBCOSBNVFEIW-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- MSTDXOZUKAQDRL-UHFFFAOYSA-N 4-Chromanone Chemical compound C1=CC=C2C(=O)CCOC2=C1 MSTDXOZUKAQDRL-UHFFFAOYSA-N 0.000 description 1
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- KYNSBQPICQTCGU-UHFFFAOYSA-N Benzopyrane Chemical group C1=CC=C2C=CCOC2=C1 KYNSBQPICQTCGU-UHFFFAOYSA-N 0.000 description 1
- SAIKULLUBZKPDA-UHFFFAOYSA-N Bis(2-ethylhexyl) amine Chemical compound CCCCC(CC)CNCC(CC)CCCC SAIKULLUBZKPDA-UHFFFAOYSA-N 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical class O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- LKJPYSCBVHEWIU-UHFFFAOYSA-N N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Chemical compound C=1C=C(C#N)C(C(F)(F)F)=CC=1NC(=O)C(O)(C)CS(=O)(=O)C1=CC=C(F)C=C1 LKJPYSCBVHEWIU-UHFFFAOYSA-N 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 101100007538 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cpc-1 gene Proteins 0.000 description 1
- 208000037581 Persistent Infection Diseases 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 229940078456 calcium stearate Drugs 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- DGJMPUGMZIKDRO-UHFFFAOYSA-N cyanoacetamide Chemical compound NC(=O)CC#N DGJMPUGMZIKDRO-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZWWWLCMDTZFSOO-UHFFFAOYSA-N diethoxyphosphorylformonitrile Chemical compound CCOP(=O)(C#N)OCC ZWWWLCMDTZFSOO-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical class CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 125000002587 enol group Chemical group 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-N ethanesulfonic acid Chemical class CCS(O)(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-N 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- DZFYOYRNBGNPJW-UHFFFAOYSA-N ethoxythallium Chemical compound [Tl+].CC[O-] DZFYOYRNBGNPJW-UHFFFAOYSA-N 0.000 description 1
- WYQYDIOILGQMHT-UHFFFAOYSA-N ethyl 2-cyano-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanoate Chemical compound C1OC2=CC=CC=C2C2=C1C(C(=O)C(C#N)C(=O)OCC)=NN2C1=CC=CC=C1 WYQYDIOILGQMHT-UHFFFAOYSA-N 0.000 description 1
- QSAPGDZPCWYLBS-UHFFFAOYSA-N ethyl 2-oxo-2-(4-oxo-2,3-dihydrothiochromen-3-yl)acetate Chemical compound C1=CC=C2C(=O)C(C(=O)C(=O)OCC)CSC2=C1 QSAPGDZPCWYLBS-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000007888 film coating Substances 0.000 description 1
- 238000009501 film coating Methods 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960004393 lidocaine hydrochloride Drugs 0.000 description 1
- YECIFGHRMFEPJK-UHFFFAOYSA-N lidocaine hydrochloride monohydrate Chemical compound O.[Cl-].CC[NH+](CC)CC(=O)NC1=C(C)C=CC=C1C YECIFGHRMFEPJK-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- YPLIFKZBNCNJJN-UHFFFAOYSA-N n,n-bis(ethylamino)ethanamine Chemical compound CCNN(CC)NCC YPLIFKZBNCNJJN-UHFFFAOYSA-N 0.000 description 1
- QAXZWHGWYSJAEI-UHFFFAOYSA-N n,n-dimethylformamide;ethanol Chemical compound CCO.CN(C)C=O QAXZWHGWYSJAEI-UHFFFAOYSA-N 0.000 description 1
- PLCJOHWZHPWOKJ-UHFFFAOYSA-N n-(3-acetamidophenyl)-2-cyano-3-oxo-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound CC(=O)NC1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4SC3)N(N=2)C=2C=CC=CC=2)=C1 PLCJOHWZHPWOKJ-UHFFFAOYSA-N 0.000 description 1
- XWQTUXZUNAFGBO-UHFFFAOYSA-N n-(3-chlorophenyl)-2-cyano-3-[1-(4-fluorophenyl)-4h-chromeno[4,3-c]pyrazol-3-yl]-3-oxopropanamide Chemical compound C1=CC(F)=CC=C1N1C(C2=CC=CC=C2OC2)=C2C(C(=O)C(C#N)C(=O)NC=2C=C(Cl)C=CC=2)=N1 XWQTUXZUNAFGBO-UHFFFAOYSA-N 0.000 description 1
- LEHFFDJPBGHSSH-UHFFFAOYSA-N n-(3-chlorophenyl)-2-cyano-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound ClC1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4OC3)N(N=2)C=2C=CC=CC=2)=C1 LEHFFDJPBGHSSH-UHFFFAOYSA-N 0.000 description 1
- SXNSMTFYBKURQX-UHFFFAOYSA-N n-(3-chlorophenyl)-2-cyano-3-oxo-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanamide Chemical compound ClC1=CC=CC(NC(=O)C(C#N)C(=O)C=2C3=C(C4=CC=CC=C4SC3)N(N=2)C=2C=CC=CC=2)=C1 SXNSMTFYBKURQX-UHFFFAOYSA-N 0.000 description 1
- VPAMVJQOXMHFRM-UHFFFAOYSA-N n-(4-chlorophenyl)-2-cyano-2-(1-methyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)-3-oxopropanamide Chemical compound C1=2CSC3=CC=CC=C3C=2N(C)N=C1C(C=O)(C#N)C(=O)NC1=CC=C(Cl)C=C1 VPAMVJQOXMHFRM-UHFFFAOYSA-N 0.000 description 1
- YVVSCBIIRYXGOH-UHFFFAOYSA-N n-(4-chlorophenyl)-2-cyano-3-oxo-3-(1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)propanethioamide Chemical compound C1=CC(Cl)=CC=C1NC(=S)C(C#N)C(=O)C1=NN(C=2C=CC=CC=2)C2=C1COC1=CC=CC=C21 YVVSCBIIRYXGOH-UHFFFAOYSA-N 0.000 description 1
- DWKSPVJAGLQFHF-UHFFFAOYSA-N n-(4-chlorophenyl)-2-cyano-3-oxo-3-(1-phenyl-4h-thiochromeno[4,3-c]pyrazol-3-yl)propanethioamide Chemical compound C1=CC(Cl)=CC=C1NC(=S)C(C#N)C(=O)C1=NN(C=2C=CC=CC=2)C2=C1CSC1=CC=CC=C21 DWKSPVJAGLQFHF-UHFFFAOYSA-N 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- WGUOSDYPVZNKBM-UHFFFAOYSA-N n-benzyl-2-cyano-3-[1-(4-fluorophenyl)-4h-thiochromeno[4,3-c]pyrazol-3-yl]-3-oxopropanamide Chemical compound C1=CC(F)=CC=C1N1C(C2=CC=CC=C2SC2)=C2C(C(=O)C(C#N)C(=O)NCC=2C=CC=CC=2)=N1 WGUOSDYPVZNKBM-UHFFFAOYSA-N 0.000 description 1
- STIDVQXSAHAXSP-UHFFFAOYSA-N n-benzyl-3-(8-chloro-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-2-cyano-3-oxopropanamide Chemical compound C1=2C3=CC(Cl)=CC=C3OCC=2C(C(=O)C(C#N)C(=O)NCC=2C=CC=CC=2)=NN1C1=CC=CC=C1 STIDVQXSAHAXSP-UHFFFAOYSA-N 0.000 description 1
- RYZYAQSJBZPDEN-UHFFFAOYSA-N n-benzyl-3-(8-chloro-4-methyl-1-phenyl-4h-chromeno[4,3-c]pyrazol-3-yl)-2-cyano-3-oxopropanamide Chemical compound CC1OC2=CC=C(Cl)C=C2C2=C1C(C(=O)C(C#N)C(=O)NCC=1C=CC=CC=1)=NN2C1=CC=CC=C1 RYZYAQSJBZPDEN-UHFFFAOYSA-N 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940117953 phenylisothiocyanate Drugs 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229940068984 polyvinyl alcohol Drugs 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 229920003109 sodium starch glycolate Polymers 0.000 description 1
- 229940079832 sodium starch glycolate Drugs 0.000 description 1
- 239000008109 sodium starch glycolate Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 230000004797 therapeutic response Effects 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB878700477A GB8700477D0 (en) | 1987-01-09 | 1987-01-09 | Heteroaryl 2-cyano-3-oxo-propanamide derivatives |
| GB878717282A GB8717282D0 (en) | 1987-07-22 | 1987-07-22 | Heteroaryl 3-oxo-propanenitrile derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH27000A true PH27000A (en) | 1993-02-01 |
Family
ID=26291768
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH36319A PH27000A (en) | 1987-01-09 | 1988-01-04 | Heteroaryl derivatives and pharmaceutical compositions containing them |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US4816467A (ja) |
| EP (1) | EP0274443B1 (ja) |
| JP (1) | JP2672312B2 (ja) |
| KR (1) | KR960002852B1 (ja) |
| CN (1) | CN1025500C (ja) |
| AU (1) | AU598893B2 (ja) |
| CA (1) | CA1310647C (ja) |
| CZ (1) | CZ277972B6 (ja) |
| DE (1) | DE3862937D1 (ja) |
| DK (1) | DK8088A (ja) |
| ES (1) | ES2029003T3 (ja) |
| FI (1) | FI89489C (ja) |
| GR (1) | GR3002032T3 (ja) |
| HU (1) | HU198722B (ja) |
| IE (1) | IE60620B1 (ja) |
| IL (1) | IL85004A (ja) |
| MY (1) | MY103348A (ja) |
| NO (1) | NO165841C (ja) |
| NZ (1) | NZ223113A (ja) |
| PH (1) | PH27000A (ja) |
| PT (1) | PT86516B (ja) |
| SU (1) | SU1695826A3 (ja) |
| YU (2) | YU46787B (ja) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0286346B1 (en) * | 1987-04-09 | 1994-04-06 | E.I. Du Pont De Nemours And Company | Insecticidal substituted indazoles |
| GB8814587D0 (en) * | 1988-06-20 | 1988-07-27 | Erba Carlo Spa | Condensed pyrazole 3-oxo-propanenitrile derivatives & process for their preparation |
| GB8814586D0 (en) * | 1988-06-20 | 1988-07-27 | Erba Carlo Spa | Tricyclic 3-oxo-propanenitrile derivatives & process for their preparation |
| GB2227741B (en) * | 1989-02-06 | 1992-08-05 | Erba Carlo Spa | Condensed 3-oxo-propanenitrile derivatives and process for their preparation |
| US5260328A (en) * | 1989-04-06 | 1993-11-09 | Farmitalia Carlo Erba Srl | Phenyl-indenopurazol 3-oxo-propanamide derivatives useful in the treatment of rheumatoid arthritis |
| GB8907799D0 (en) * | 1989-04-06 | 1989-05-17 | Erba Carlo Spa | Heteroaryl-3-oxo-propanenitrile derivatives useful in the treatment of rheumatoid arthritis and other autoimmune diseases |
| GB8916290D0 (en) * | 1989-07-17 | 1989-08-31 | Erba Carlo Spa | Heteroaryl-3-oxo-propanenitrile derivatives useful in stimulating myelopoiesis |
| DK0527736T3 (da) * | 1990-05-18 | 1997-10-20 | Hoechst Ag | Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler. |
| US5547975A (en) * | 1994-09-20 | 1996-08-20 | Talley; John J. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| US5886016A (en) * | 1995-09-15 | 1999-03-23 | G.D. Searle & Co. | Benzopyranopyrazolyl derivatives for the treatment of inflammation |
| GB9720899D0 (en) * | 1997-10-01 | 1997-12-03 | Pharmacia & Upjohn Spa | Condensed heterocyclic compounds |
| AU2001247616B2 (en) * | 2000-04-11 | 2007-06-14 | Genentech, Inc. | Multivalent antibodies and uses therefor |
| MXPA04002682A (es) * | 2001-09-19 | 2004-06-18 | Pharmacia Corp | Compuestos pirazolilo sustituidos para el tratamiento de la inflamacion. |
| EP1651276A4 (en) * | 2003-08-08 | 2009-05-06 | Barnes Jewish Hospital | EMULSION PARTICLES FOR IMAGING AND THERAPY AND USE METHOD THEREFOR |
| US20060035242A1 (en) | 2004-08-13 | 2006-02-16 | Michelitsch Melissa D | Prion-specific peptide reagents |
| CA2650574A1 (en) * | 2006-04-27 | 2007-11-08 | Barnes-Jewish Hospital | Detection and imaging of target tissue |
| EP2499146B1 (en) * | 2009-11-13 | 2016-09-21 | Merck Serono S.A. | Tricyclic pyrazol amine derivatives |
| CN102086212B (zh) * | 2009-12-03 | 2013-06-12 | 沈阳药科大学 | 抗真菌剂-2，3，4，5-四氢-4H-苯并[b]噻喃并[4，3-c]吡唑-2-甲酰胺衍生物 |
| WO2018075564A1 (en) | 2016-10-17 | 2018-04-26 | University Of Maryland, College Park | Multispecific antibodies targeting human immunodeficiency virus and methods of using the same |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4268516A (en) * | 1978-10-11 | 1981-05-19 | Pfizer Inc. | [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents |
| EP0022446A1 (de) * | 1979-04-06 | 1981-01-21 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Verfahren zur Herstellung von Biotinestern und von Biotin |
| EP0057932A1 (en) * | 1981-02-11 | 1982-08-18 | E.I. Du Pont De Nemours And Company | Antiinflammatory and/or analgesic 3,4-dihydro(or 1,4-dihydro)-2-((substituted)thiol)-(1)-benzopyrano(3,4-d)imidazoles and their corresponding sulfoxides and sulfones |
| PH21213A (en) * | 1984-10-26 | 1987-08-21 | Fujisawa Pharmaceutical Co | Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same |
-
1987
- 1987-12-31 US US07/140,221 patent/US4816467A/en not_active Expired - Fee Related
-
1988
- 1988-01-01 IL IL85004A patent/IL85004A/xx not_active IP Right Cessation
- 1988-01-04 PH PH36319A patent/PH27000A/en unknown
- 1988-01-04 IE IE288A patent/IE60620B1/en not_active IP Right Cessation
- 1988-01-05 AU AU10037/88A patent/AU598893B2/en not_active Ceased
- 1988-01-06 YU YU1088A patent/YU46787B/sh unknown
- 1988-01-07 CZ CS88179A patent/CZ277972B6/cs not_active IP Right Cessation
- 1988-01-07 CA CA000556010A patent/CA1310647C/en not_active Expired - Fee Related
- 1988-01-07 CN CN88100153A patent/CN1025500C/zh not_active Expired - Fee Related
- 1988-01-07 NZ NZ223113A patent/NZ223113A/xx unknown
- 1988-01-08 FI FI880078A patent/FI89489C/fi not_active IP Right Cessation
- 1988-01-08 SU SU884355070A patent/SU1695826A3/ru active
- 1988-01-08 KR KR1019880000056A patent/KR960002852B1/ko active IP Right Grant
- 1988-01-08 DE DE8888300115T patent/DE3862937D1/de not_active Expired - Fee Related
- 1988-01-08 DK DK008088A patent/DK8088A/da not_active Application Discontinuation
- 1988-01-08 NO NO880068A patent/NO165841C/no unknown
- 1988-01-08 JP JP63002374A patent/JP2672312B2/ja not_active Expired - Lifetime
- 1988-01-08 MY MYPI88000014A patent/MY103348A/en unknown
- 1988-01-08 ES ES198888300115T patent/ES2029003T3/es not_active Expired - Lifetime
- 1988-01-08 EP EP88300115A patent/EP0274443B1/en not_active Expired - Lifetime
- 1988-01-08 HU HU8858A patent/HU198722B/hu not_active IP Right Cessation
- 1988-01-08 PT PT86516A patent/PT86516B/pt not_active IP Right Cessation
-
1989
- 1989-04-18 YU YU00794/89A patent/YU79489A/xx unknown
-
1991
- 1991-05-30 GR GR91400684T patent/GR3002032T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH27000A (en) | Heteroaryl derivatives and pharmaceutical compositions containing them | |
| US4482555A (en) | Substituted 1H-pyrazolo (1,5-a) pyrimidines and process for their preparation | |
| EP0347773B1 (en) | Condensed pyrazole 3-oxo-propanenitrile derivatives and process for their preparation | |
| EP0181136B1 (en) | Oxindole antiinflammatory agents | |
| CA1309407C (en) | Cinnoline-carboxamides and process for their preparation | |
| US5166152A (en) | Tricyclic 3-oxo-propanenitrile derivatives | |
| US4239887A (en) | Pyridothienotriazines | |
| US4898867A (en) | Thienopyrimidine derivaties as aldose-reductase inhibitors | |
| EP0322153A2 (en) | Heterocyclic oxophtalazinyl acetic acids | |
| US4482559A (en) | 4-Phenyl-4,5,6,7-tetrahydro-thieno [2,3-c]pyridines, compositions and use | |
| EP0278603B1 (en) | Condensed pyrazole derivatives and process for their preparation | |
| KR20020075442A (ko) | 티에노피리딘 유도체, 이의 제조 및 용도 | |
| US4431657A (en) | Analgesic compositions consisting of 2H-benzothieno[3,2-c]pyrazol-3-amine derivatives | |
| EP0284018B1 (en) | Benzopyran[4,3-d]-thiazole-derivatives with anti-allergic, anti-anaphylactic and anti-arthritic activity and compositions containing them | |
| KR900006992B1 (ko) | 티에닐티아졸 화합물의 제조방법 | |
| NO885771L (no) | Fremgangsmaate for fremstilling av heterocykliske oksoftalazinyl-eddiksyrer. |